The prevalence of hypomagnesemia in a representative population from northeastern Iran

Main Article Content

Majid Ghayour Mobarhan
Majid Gohari-Kahou
Maryam Saberi karimian
elham barati
hamideh Qazizadeh
ali javandoust
mohammad safarian
mohsen mouhebati
mahmoud ebrahimi
Gordon A.Ferns
hamid reza kazerani

Keywords

Magnesium; BMI; Cardiovascular disease

Abstract

Background: Magnesium (Mg2+) is an important cation involved in several biochemical and physiological functions. It plays a key role in the activity of enzymes involved in the metabolism of carbohydrates, lipids and proteins. Hypomagnesemia (a low value of serum magnesium) has been reported in metabolic syndrome, diabetes and cardiovascular disease. In the current study we have assessed the prevalence of the hypomagnesemia among Iranian adults. Methods: A total of 853 participants were recruited as part of the MASHAD study, a cohort study of subjects (aged 35-65 years) .The subjects were divided into three age groups:  35-44.9, 45-54.9 and 55-64.9 years old. Anthropometric indices including weight and height were measured by standard methods. Serum Mg concentrations were measured using fasting blood samples, taken from all participants and were measured using the xylidyl blue photometric method (Pars Azmoon kit; Tehran, Iran) on a BT3000 auto analyser. Data analyzes were performed using SPSS version 20 (Chicago-USA). A p-value less than 0.05 was considered statistically significant. Results: In the study population, the mean serum Mg concentration was 1.03±0.16 mg/dl. The prevalence of a low serum magnesium (defined as magnesium <0.94 mg/dl) was 25.8%, 23.13% and 28.1%, in the total population, and in men, and women respectively. There was no significant difference in serum Mg level between men and women (P>0.05). Moreover, there were no significant differences in the prevalence of low value of serum magnesium and serum Mg concentrations in total population, males and females for the three age groups (P<0.05). There was not a significant difference between mg level and anxiety and depression scores in different groups of sex and age. After adjusting for confounding factors, there was a significant association between BMI and % body fat with serum Mg level (P<0.05). Conclusions: The prevalence of the low value of serum magnesium was 25.8% in northeastern Iran. There was a significant association between a low serum magnesium level and BMI and % body fat.

Downloads

Download data is not yet available.
Abstract 21 |

References

1. Witkowski M, Hubert J, Mazur A. Methods of assessment of magnesium status in humans: a systematic review. Magnesium research. 2012;24(4):163-80.
2. Glasdam S-M, Glasdam S, Peters GH. The importance of magnesium in the human body: a systematic literature review. Advances in clinical chemistry. 73: Elsevier; 2016. p. 169-93.
3. Viering DHM, de Baaij JH, Walsh SB, Kleta R, Bockenhauer D. Genetic causes of hypomagnesemia, a clinical overview. Pediatric Nephrology. 2017;32(7):1123-35.
4. Gröber U, Schmidt J, Kisters K. Magnesium in prevention and therapy. Nutrients. 2015;7(9):8199-226.
5. Guerrera MP, Volpe SL, Mao JJ. Therapeutic uses of magnesium. American family physician. 2009;80(2).
6. Nielsen FH, Lukaski HC. Update on the relationship between magnesium and exercise. Magnesium research. 2006;19(3):180-9.
7. Nielsen FH. Guidance for the determination of status indicators and dietary requirements for magnesium. Magnesium research. 2016;29(4):154-60.
8. Chandrasekaran NC, Sanchez WY, Mohammed YH, Grice JE, Roberts MS, Barnard RT. Permeation of topically applied Magnesium ions through human skin is facilitated by hair follicles. Magnesium research. 2016;29(2):35-42.
9. Del Gobbo LC, Song Y, Poirier P, Dewailly E, Elin RJ, Egeland GM. Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes. Cardiovascular diabetology. 2012;11(1):23.
10. Polderman KH, Peerdeman SM, Girbes AR. Hypophosphatemia and hypomagnesemia induced by cooling in patients with severe head injury. Journal of neurosurgery. 2001;94(5):697-705.
11. Regolisti G, Cabassi A, Parenti E, Maggiore U, Fiaccadori E. Severe hypomagnesemia during long-term treatment with a proton pump inhibitor. American journal of kidney diseases. 2010 Jul 1;56(1):168-74.
12. Hansen KE, Nabak AC, Johnson RE, Marvdashti S, Keuler NS, Shafer MM, et al. Isotope Concentrations from 24-h Urine and 3-h Serum Samples Can Be Used to Measure Intestinal Magnesium Absorption in Postmenopausal Women–3. The Journal of nutrition. 2014;144(4):533-7.
13. Shechter M. Magnesium and cardiovascular system. Magnesium research. 2010;23(2):60-72.
14. Derom M-L, Sayón-Orea C, Martínez-Ortega JM, Martínez-González MA. Magnesium and depression: a systematic review. Nutritional neuroscience. 2013;16(5):191-206.
15. Yary T, Aazami S, Soleimannejad K. Dietary intake of magnesium may modulate depression. Biological trace element research. 2013;151(3):324-9.
26. Houston M. The role of magnesium in hypertension and cardiovascular disease. The Journal of Clinical Hypertension. 2011;13(11):843-7.
17. Ghayour-Mobarhan M, Moohebati M, Esmaily H, Ebrahimi M, Parizadeh SMR, Heidari-Bakavoli AR, et al. Mashhad stroke and heart atherosclerotic disorder (MASHAD) study: design, baseline characteristics and 10-year cardiovascular risk estimation. International journal of public health. 2015;60(5):561-72.
18. Alan S L Yu, MB, BChir, Editors (Stanley Goldfarb, Albert Q Lam). Causes of hypomagnesemia. https://www.uptodate.com/contents/causes-of-hypomagnesemia, Topic 829 Version 35.0
19.Vasconcellos MT, Anjos LA. 2003. A simplified method for assessing physical activity level values for a country or study population. European Journal of Clinical Nutrition 57:1025-33. doi:10.1038/sj.ejcn.1601638.
20.Sekita A, Arima H, Ninomiya T, Ohara T, Doi Y, Hirakawa Y, et al. 2013. Elevated depressive symptoms in metabolic syndrome in a general population of Japanese men: a cross-sectional study. BMC public health 13:862. Epub 2013/09/21.
21. Al Alawi AM, Majoni SW, Falhammar H. Magnesium and Human Health: Perspectives and Research Directions. International journal of endocrinology. 2018;2018.
22. Ghasemi A, Syedmoradi L, Zahediasl S, Azizi F. Pediatric reference values for serum magnesium levels in Iranian subjects. Scandinavian journal of clinical and laboratory investigation. 2010;70(6):415-20.
23. Syedmoradi L, Ghasemi A, Zahediasl S, Azizi F. Prevalence of hypo-and hypermagnesemia in an Iranian urban population. Annals of human biology. 2011;38(2):150-5.
24. Schimatschek HF, Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnesium research. 2001;14(4):283-90.
25. Singh R, Rastogi V, Singh R, Niaz M, Srivastav S, Aslam M, et al. Magnesium and antioxidant vitamin status and risk of complications of ageing in an elderly urban population. Magnesium research. 1996;9(4):299-306.
26. Liamis G, Rodenburg EM, Hofman A, Zietse R, Stricker BH, Hoorn EJ. Electrolyte disorders in community subjects: prevalence and risk factors. The American journal of medicine. 2013;126(3):256-63.
27. Elamin A, Tuvemo T. Magnesium and insulin-dependent diabetes mellitus. Diabetes research and clinical practice. 1990;10(3):203-9.
28. Rajizadeh A, Mozaffari-Khosravi H, Yassini-Ardakani M, Dehghani A. Serum magnesium status in patients subjects with depression in the city of Yazd in Iran 2013–2014. Biological trace element research. 2016;171(2):275-82.
29. Fox CH, Ramsoomair D, Mahoney MC, Carter C, Young B, Graham R. An investigation of hypomagnesemia among ambulatory urban African Americans. The Journal of family practice. 1999;48(8):636-9.
30. Arpaci D, Tocoglu AG, Ergenc H, Korkmaz S, Ucar A, Onmez A, et al., editors. Associations of serum magnesium levels with diabetes and diabetic complications. 17th European Congress of Endocrinology; 2015: BioScientifica.
31. Babikr WG, Shalayel MH, Abdelraheem AH, Elhussein AB. Impact of body mass index on hypomagnesemia and hypocalcemia in type 2 diabetic patients. Biomedical and Pharmacology Journal. 2016;9(3):933-40.
32. Lecube A, Baena-Fustegueras JA, Fort JM, Pelegrí D, Hernández C, Simó R. Diabetes is the main factor accounting for hypomagnesemia in obese subjects. PLoS One. 2012;7(1):e30599.
33. Huang J-H, Lu Y-F, Cheng F-C, Lee JN-Y, Tsai L-C. Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: a cross-sectional study. Nutrition journal. 2012;11(1):41.
34. Bertinato J, Xiao CW, Ratnayake WN, Fernandez L, Lavergne C, Wood C, et al. Lower serum magnesium concentration is associated with diabetes, insulin resistance, and obesity in South Asian and white Canadian women but not men. Food & nutrition research. 2015;59(1):25974.
35. Agus ZS. Hypomagnesemia. Journal of the American Society of Nephrology. 1999;10(7):1616-22.

Most read articles by the same author(s)